Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.98 USD | +1.32% | -0.65% | +3.39% |
18/04 | Oppenheimer Raises Avient Price Target to $49 From $45, Maintains Outperform Rating | MT |
15/02 | Deutsche Bank Adjusts Avient Price Target to $42 From $37, Maintains Hold Rating | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company sustains low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company benefits from high valuations in earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.39% | 3.92B | A- | ||
+13.43% | 64.32B | A- | ||
-3.73% | 45.95B | A- | ||
+14.29% | 39.61B | B+ | ||
+20.84% | 25.74B | A- | ||
+9.03% | 18.75B | C+ | ||
-0.60% | 17.23B | B+ | ||
-21.03% | 15.86B | A- | ||
+1.36% | 15.03B | B+ | ||
-17.64% | 13.99B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AVNT Stock
- Ratings Avient Corporation